Xia S - Search Results

1

Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation.

Xia S, Lan Q, Zhu Y, Wang C, Xu W, Li Y, Wang L, Jiao F, Zhou J, Hua C, Wang Q, Cai X, Wu Y, Gao J, Liu H, Sun G, Münch J, Kirchhoff F, Yuan Z, Xie Y, Sun F, Jiang S, Lu L. Xia S, et al. Signal Transduct Target Ther. 2021 Jul 29;6(1):288. doi: 10.1038/s41392-021-00712-2. Signal Transduct Target Ther. 2021. PMID: 34326308 Free PMC article.

2

[The detection of pediatric mycoplasma pneumonia cases by polymerase chain reaction and it's clinical significance].

Wang Q, Xia SY, Long JQ. Wang Q, et al. Among authors: xia sy. Zhonghua Liu Xing Bing Xue Za Zhi. 1996 Dec;17(6):350-2. Zhonghua Liu Xing Bing Xue Za Zhi. 1996. PMID: 9387601 Chinese.

3

Testing of Middle East respiratory syndrome coronavirus replication inhibitors for the ability to block viral entry.

Liu Q, Xia S, Sun Z, Wang Q, Du L, Lu L, Jiang S. Liu Q, et al. Among authors: xia s. Antimicrob Agents Chemother. 2015 Jan;59(1):742-4. doi: 10.1128/AAC.03977-14. Epub 2014 Oct 20. Antimicrob Agents Chemother. 2015. PMID: 25331705 Free PMC article. No abstract available.

4

Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein.

Xia S, Liu Q, Wang Q, Sun Z, Su S, Du L, Ying T, Lu L, Jiang S. Xia S, et al. Virus Res. 2014 Dec 19;194:200-10. doi: 10.1016/j.virusres.2014.10.007. Epub 2014 Oct 14. Virus Res. 2014. PMID: 25451066 Free PMC article. Review.

5

Intranasal administration of maleic anhydride-modified human serum albumin for pre-exposure prophylaxis of respiratory syncytial virus infection.

Sun Z, Wang Q, Jia R, Xia S, Li Y, Liu Q, Xu W, Xu J, Du L, Lu L, Jiang S. Sun Z, et al. Among authors: xia s. Viruses. 2015 Feb 16;7(2):798-819. doi: 10.3390/v7020798. Viruses. 2015. PMID: 25690799 Free PMC article.

6

Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection.

Channappanavar R, Lu L, Xia S, Du L, Meyerholz DK, Perlman S, Jiang S. Channappanavar R, et al. Among authors: xia s. J Infect Dis. 2015 Dec 15;212(12):1894-903. doi: 10.1093/infdis/jiv325. Epub 2015 Jun 8. J Infect Dis. 2015. PMID: 26164863 Free PMC article.

7

Putative suppressing effect of IgG Fc-conjugated haemagglutinin (HA) stalk of influenza virus H7N9 on the neutralizing immunogenicity of Fc-conjugated HA head: implication for rational design of HA-based influenza vaccines.

He B, Xia S, Yu F, Fu Y, Li W, Wang Q, Lu L, Jiang S. He B, et al. Among authors: xia s. J Gen Virol. 2016 Feb;97(2):327-333. doi: 10.1099/jgv.0.000365. Epub 2015 Dec 9. J Gen Virol. 2016. PMID: 26653217

8

Urgent development of effective therapeutic and prophylactic agents to control the emerging threat of Middle East respiratory syndrome (MERS).

Lu L, Xia S, Ying T, Jiang S. Lu L, et al. Among authors: xia s. Emerg Microbes Infect. 2015 Jun 17;4(6):e37. doi: 10.1038/emi.2015.37. Emerg Microbes Infect. 2015. PMID: 26954884 Free PMC article. No abstract available.

9

Intranasal application of polyethyleneimine suppresses influenza virus infection in mice.

He B, Fu Y, Xia S, Yu F, Wang Q, Lu L, Jiang S. He B, et al. Among authors: xia s. Emerg Microbes Infect. 2016 Apr 27;5(4):e41. doi: 10.1038/emi.2016.64. Emerg Microbes Infect. 2016. PMID: 27118070 Free PMC article. No abstract available.

10

[Development of peptidic MERS-CoV entry inhibitors].

Xia S, Wang Q, Liu SW, Lu L, Jiang SB. Xia S, et al. Yao Xue Xue Bao. 2015 Dec;50(12):1513-9. Yao Xue Xue Bao. 2015. PMID: 27169270 Review. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,381 results

Search Page

Filters